Back

Myricetin allosterically inhibits Dengue NS2B-NS3 protease as studied by NMR and MD simulations

Dang, M.; Song, J.

2021-12-14 biophysics
10.1101/2021.12.13.472523 bioRxiv
Show abstract

Dengue NS2B-NS3 protease existing in equilibrium between the active and inactive forms is essential for virus replication, thus representing a key drug target. Here Myricetin, a plant flavonoid, was characterized to non-competitively inhibit Dengue protease. Further NMR study identified the protease residues perturbed by binding to Myricetin, which were utilized to construct the Myricetin-protease complexes. Strikingly, in the active form Myricetin binds a new allosteric site (AS2) far away from the active site pocket and allosteric site (AS1) for binding Curcumin, while in the inactive form it binds both AS1 and AS2. To decipher the mechanism for the allosteric inhibition by Myricetin, we conducted molecular dynamics (MD) simulations on different forms of Dengue NS2B-NS3 protease. Unexpectedly, the binding of Myricetin to AS2 is sufficient to disrupt the active conformation by displacing the characteristic NS2B C-terminal {beta}- hairpin from the active site pocket. By contrast, the binding of Myricetin to AS1 and AS2 results in locking the inactive conformation. Therefore Myricetin represents the first small molecule which allosterically inhibits Dengue protease by both disrupting the active conformation and locking the inactive conformation. The results enforce the notion that a global allosteric network exists in Dengue NS2B-NS3 protease, which is susceptible to allosteric inhibition by small molecules such as Myricetin and Curcumin. As Myricetin has been extensively used as a food additive, it might be directly utilized to fight the Dengue infections and as a promising starting for further design of potent allosteric inhibitors. Graphic Abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=117 SRC="FIGDIR/small/472523v1_ufig1.gif" ALT="Figure 1"> View larger version (29K): org.highwire.dtl.DTLVardef@ec52d1org.highwire.dtl.DTLVardef@1313dc4org.highwire.dtl.DTLVardef@1ce40b5org.highwire.dtl.DTLVardef@1fa6051_HPS_FORMAT_FIGEXP M_FIG C_FIG

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
Journal of Biomolecular Structure and Dynamics
43 papers in training set
Top 0.1%
23.4%
2
Journal of Chemical Information and Modeling
207 papers in training set
Top 0.6%
8.8%
3
PLOS ONE
4510 papers in training set
Top 26%
6.6%
4
Virus Research
36 papers in training set
Top 0.2%
3.7%
5
ACS Chemical Neuroscience
60 papers in training set
Top 0.5%
3.7%
6
Frontiers in Molecular Biosciences
100 papers in training set
Top 0.3%
3.7%
50% of probability mass above
7
Chemistry – A European Journal
13 papers in training set
Top 0.1%
3.2%
8
Molecules
37 papers in training set
Top 0.4%
2.7%
9
eLife
5422 papers in training set
Top 31%
2.7%
10
The Journal of Physical Chemistry B
158 papers in training set
Top 0.8%
2.2%
11
Scientific Reports
3102 papers in training set
Top 49%
2.2%
12
Journal of Molecular Graphics and Modelling
16 papers in training set
Top 0.1%
2.2%
13
The Journal of Physical Chemistry Letters
58 papers in training set
Top 0.7%
2.0%
14
Viruses
318 papers in training set
Top 3%
1.8%
15
Computational and Structural Biotechnology Journal
216 papers in training set
Top 5%
1.5%
16
International Journal of Molecular Sciences
453 papers in training set
Top 8%
1.5%
17
PLOS Computational Biology
1633 papers in training set
Top 19%
1.3%
18
Frontiers in Chemistry
14 papers in training set
Top 0.2%
1.2%
19
ACS Omega
90 papers in training set
Top 3%
1.0%
20
International Journal of Biological Macromolecules
65 papers in training set
Top 3%
0.9%
21
Biomolecules
95 papers in training set
Top 1%
0.9%
22
Frontiers in Pharmacology
100 papers in training set
Top 4%
0.9%
23
Biophysical Chemistry
14 papers in training set
Top 0.1%
0.9%
24
Journal of Molecular Biology
217 papers in training set
Top 3%
0.8%
25
Biophysics and Physicobiology
10 papers in training set
Top 0.2%
0.8%
26
Chemical Communications
24 papers in training set
Top 1%
0.8%
27
Biochemistry and Biophysics Reports
28 papers in training set
Top 2%
0.7%
28
Journal of Medicinal Chemistry
68 papers in training set
Top 2%
0.5%
29
Virology
56 papers in training set
Top 0.9%
0.5%